Skip to main content
letter
. 2022 May 18;269(9):4618–4622. doi: 10.1007/s00415-022-11188-7

Fig. 1.

Fig. 1

a, b Spinal cord lesions identified at C7, C7-Th1, Th5-Th6 and Th11-Th12 levels (T2-STIR sequence); none of the lesions presented gadolinium enhancement; c, d spinal cord lesion at C7 level and at D4 level in an axial view (T2-sequence sequence); e, f improvement of the lesions previously identified on the follow-up MRI at 4 months